More articles from METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

You have access
Probing the Assembly of HDL Mimetic, Drug Carrying Nanoparticles, using Intrinsic Fluorescence
Sangram G Raut, Ashwini Garud, Bhavani Nagarajan, Nirupama Sabnis, Alan Remaley, Rafal Fudala, Ignacy Gryczynski, Zygmunt Gryczynski, Sergei V Dzyuba, Julian Borejdo and Andras G Lacko

Journal of Pharmacology and Experimental Therapeutics January 15, 2020, jpet.119.262899; DOI: https://doi.org/10.1124/jpet.119.262899
You have access
From genotype to phenotype: content and activities of cytochromes P450 2A6 in human liver in vitro and predicted in vivo
Yan Fang, Tong Wang, Yuan-Yuan Guo, Hai-Feng Zhang, Qiang Wen, Yu-Rong Xing, Na Gao and Hai-Ling Qiao

Journal of Pharmacology and Experimental Therapeutics December 27, 2019, jpet.119.263152; DOI: https://doi.org/10.1124/jpet.119.263152
You have access
Plasma Membrane Cholesterol Regulates the Allosteric Binding of 1-Methyl-4-Phenylpyridinium to Organic Cation Transporter 2 (SLC22A2)
Severin Hörmann, Zhibo Gai, Gerd A. Kullak-Ublick and Michele Visentin

Journal of Pharmacology and Experimental Therapeutics January 2020, 372 (1) 46-53; DOI: https://doi.org/10.1124/jpet.119.260877
You have access
Sampling Site Has a Critical Impact on Physiologically Based Pharmacokinetic Modeling
Weize Huang and Nina Isoherranen

Journal of Pharmacology and Experimental Therapeutics January 2020, 372 (1) 30-45; DOI: https://doi.org/10.1124/jpet.119.262154
You have access
A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model
Michelle L. Montonye, Dan-Dan Tian, Tarana Arman, Katherine D. Lynch, Bruno Hagenbuch, Mary F. Paine and John D. Clarke

Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 385-393; DOI: https://doi.org/10.1124/jpet.119.260489
You have access
CC-115, a Dual Mammalian Target of Rapamycin/DNA-Dependent Protein Kinase Inhibitor in Clinical Trial, Is a Substrate of ATP-Binding Cassette G2, a Risk Factor for CC-115 Resistance
Jenny Beebe and Jian-Ting Zhang

Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 320-326; DOI: https://doi.org/10.1124/jpet.119.258392
You have access
Direct Measurement of Kinetic Parameters of ABCG2-Dependent Transport of Natural Flavonoids Using a Fluorogenic Substrate
Michal Rozanski, Maciej Studzian and Lukasz Pulaski

Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 309-319; DOI: https://doi.org/10.1124/jpet.119.261347
Open Access
Absence of Pharmacokinetic Interactions between the Bruton’s Tyrosine Kinase Inhibitor Fenebrutinib and Methotrexate
Nicholas Steven Jones, Helen Winter, Tamiko R. Katsumoto, Marilyn Florero, Elaine Murray, Helen Walker, Nand Singh and Leslie W. Chinn

Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 202-207; DOI: https://doi.org/10.1124/jpet.119.257089
You have access
Effect of Pregnancy on Paroxetine-Induced Adiposity and Glucose Intolerance in Mice
Weibin Zha, Tao Hu, Mary F. Hebert and Joanne Wang

Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 113-120; DOI: https://doi.org/10.1124/jpet.118.255380
Open Access
Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor
Tetsuya Taniguchi, Naoki Ashizawa, Koji Matsumoto, Ryo Saito, Keisuke Motoki, Miku Sakai, Noriko Chikamatsu, Chiharu Hagihara, Masamichi Hashiba and Takashi Iwanaga

Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 162-170; DOI: https://doi.org/10.1124/jpet.119.259341

Main menu

User menu

Search

More articles from METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

Pages

Navigate

More Information

ASPET's Other Journals